Cargando…
The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial()
BACKGROUND: Asymptomatic low-density gametocyte carriers represent the majority of malaria-infected individuals. However, the impact of recommended treatment with single low dose of primaquine and an artemisinin-based combination therapy to reduce transmission in this group is unknown. METHODS: This...
Autores principales: | Okebe, Joseph, Bousema, Teun, Affara, Muna, Di Tanna, Gian Luca, Dabira, Edgard, Gaye, Abdoulaye, Sanya-Isijola, Frank, Badji, Henry, Correa, Simon, Nwakanma, Davis, Van Geertruyden, Jean-Pierre, Drakeley, Chris, D'Alessandro, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264436/ https://www.ncbi.nlm.nih.gov/pubmed/27825738 http://dx.doi.org/10.1016/j.ebiom.2016.10.032 |
Ejemplares similares
-
The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial
por: Okebe, Joseph, et al.
Publicado: (2015) -
Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study
por: Mwesigwa, Julia, et al.
Publicado: (2019) -
Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial
por: Soumare, Harouna M., et al.
Publicado: (2022) -
CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
por: Pett, Helmi, et al.
Publicado: (2019) -
Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity
por: Chotsiri, Palang, et al.
Publicado: (2022)